Palisades Hudson Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$249K Hold
1,792
0.1% 89
2025
Q4
$220K Buy
+1,792
New +$218K 0.09% 95
2025
Q2
Sell
-1,792
Closed -$201K 111
2025
Q1
$201K Buy
+1,792
New +$185K 0.09% 97
2020
Q3
Sell
-2,960
Closed -$228K 97
2020
Q2
$228K Hold
2,960
0.16% 82
2020
Q1
$221K Buy
+2,960
New +$205K 0.19% 73
2019
Q1
Sell
-3,790
Closed -$237K 104
2018
Q4
$237K Hold
3,790
0.14% 96
2018
Q3
$293K Hold
3,790
0.15% 91
2018
Q2
$268K Hold
3,790
0.14% 91
2018
Q1
$286K Hold
3,790
0.16% 88
2017
Q4
$272K Hold
3,790
0.15% 91
2017
Q3
$307K Hold
3,790
0.17% 79
2017
Q2
$268K Hold
3,790
0.16% 92
2017
Q1
$257K Hold
3,790
0.16% 83
2016
Q4
$271K Hold
3,790
0.17% 75
2016
Q3
$300K Hold
3,790
0.23% 64
2016
Q2
$316K Hold
3,790
0.26% 60
2016
Q1
$348K Hold
3,790
0.27% 52
2015
Q4
$384K Hold
3,790
0.32% 43
2015
Q3
$372K Hold
3,790
0.33% 41
2015
Q2
$443K Hold
3,790
0.38% 35
2015
Q1
$372K Hold
3,790
0.29% 46
2014
Q4
$357K Hold
3,790
0.28% 53
2014
Q3
$403K Hold
3,790
0.33% 36
2014
Q2
$314K Hold
3,790
0.26% 44
2014
Q1
$269K Hold
3,790
0.23% 54
2013
Q4
$285K Hold
3,790
0.24% 51
2013
Q3
$238K Buy
+3,790
New +$227K 0.21% 53

Other funds holding GILD

Palisades Hudson Asset Management's GILD Position: Q1 2026 in Review

Palisades Hudson Asset Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 1,792 shares worth $249K. The position accounts for 0.1% of the portfolio, ranked #89.

Palisades Hudson Asset Management first reported a position in GILD in Q3 2013 and has held it in 27 quarters since. The position peaked at $443K in Q2 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Palisades Hudson Asset Management held 1,792 shares of Gilead Sciences worth $249K as of Q1 2026.
  • Palisades Hudson Asset Management left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.1% of Palisades Hudson Asset Management's portfolio in Q1 2026, its #89 holding.
  • Palisades Hudson Asset Management first reported a position in Gilead Sciences in Q3 2013 and has held it in 27 quarters since.
  • Palisades Hudson Asset Management's Gilead Sciences position peaked at $443K in Q2 2015.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Palisades Hudson Asset Management's 13F filing for Q1 2026, filed 8 May 2026.